Conditions: HIV Infections
Allocation:  | Intervention model: PARALLEL
Enrollment: 85
Healthy volunteers: no

Brief summary:
The purpose of this study is to identify an optimal dose combination(s) of tipranavir (TPV) and ritonavir (RTV) for antiretroviral treatment naïve HIV-1 infected patients that can be used in pivotal trial by assessing the steady-state pharmacokinetics and short-term efficacy and safety

Detailed description:

Arms:

Interventions: intervention 1: tipranavir intervention 2: ritonavir
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: